THE WHAT? Walgreens Boots Alliance has introduced its outcomes for the primary quarter of the present monetary yr. Within the three months to November 30, 2022, the pharmacy large noticed gross sales decline 1.5 % yoy to US$333.4 billion.
THE DETAILS First quarter loss per share was US$4.31 in comparison with final yr’s US$4.13 EPS, reflecting the US$6.5 billion pre-tax cost acknowledged in reference to the beforehand introduced opioid litigation settlement frameworks.
Among the many highlights of the quarter, Boots UK reported a retail gross sales improve of 8.7 %, rising market share for the 7th consecutive quarter with footfall bettering by 8 % and Boots.com persevering with to carry out properly.
THE WHY? Chief Government Officer Rosalind Brewer commented, “WBA delivered a strong begin to the fiscal yr, as we proceed to speed up our transformation to a consumer-centric healthcare firm. We’re making vital progress in driving our US Healthcare phase to scale and revenue, together with the current VillageMD acquisition of Summit Well being. Our core retail pharmacy companies in each the US and United Kingdom stay resilient in difficult working environments. Execution throughout segments reinforces our confidence in attaining full-year steering, and our strategic actions are creating long-term shareholder worth.”